Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Conference to start in less than two hours

"This strategically significant licensing agreement with Fujitsu further validates our confidence in the superb Alliacense team of licensing professionals. "

I believe this was part of the pump that lead to the $2.00 S/P that allow ES to dump shares after the dividend disbrusement ? TPL will never change it colors. If it is not one thing there will always be another. Please get your head out of the sand. (sorry)

"Until mid-2005, Patriot had never before shown a quarterly profit,"

And why is that? Could it be that we were fighting the same people over ownership (+ CM) that we are now? Take a lesson from CM. TPL can never be trusted. CM seems to have learned his lesson, but perhaps too late. You cannot change a Tiger's stripes.

Share
New Message
Please login to post a reply